Xenon Pharmaceuticals Inc
(NAS:XENE)
$
40.76
2.12 (5.49%)
Market Cap: 3.09 Bil
Enterprise Value: 2.38 Bil
PE Ratio: 0
PB Ratio: 3.65
GF Score: 49/100 - Xenon Pharmaceuticals Inc Corporate Update TranscriptNov 27, 2023
- Q3 2023 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023$32.15 (+1.13%)Earnings
- Xenon Pharmaceuticals Inc XEN1101 and the Major Depressive Disorder (MDD) Landscape: A Discussion with KOLs TranscriptSep 19, 2023
- Q2 2023 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2023$35.45 (+0.28%)Earnings
- Xenon Pharmaceuticals Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Xenon Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Xenon Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 01, 2023
- Xenon Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Xenon Pharmaceuticals Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2023$43.54 (+2.45%)Earnings
- Xenon Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Xenon Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Q4 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2023$40.35 (+2.26%)Earnings
- Xenon Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Xenon Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022$35.4 (+1.81%)Earnings
- Q2 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2022$39.35 (-0.76%)Earnings
- Xenon Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 01, 2022
- Q1 2022 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 10, 2022$28.57 (+12.30%)Earnings
- Xenon Pharmaceuticals Inc at Bloom Burton & Co. Healthcare Investor Conference TranscriptMay 03, 2022
- Xenon Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Xenon Pharmaceuticals Inc at Stifel CNS Days (Virtual) TranscriptMar 29, 2022
- Q4 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022$31.76 (+0.19%)Earnings
- Xenon Pharmaceuticals Inc X-TOLE Results Update AES 2021 Call TranscriptDec 03, 2021
- Q3 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2021$33.79 (-4.14%)Earnings
- Xenon Pharmaceuticals Inc Positive Topline Results from Phase 2b 'X-TOLE' Clinical Trial of XEN1101 Call TranscriptOct 04, 2021
- Q2 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2021$18.68 (+11.19%)Earnings
- Xenon Pharmaceuticals Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Xenon Pharmaceuticals Inc Discussion of XEN1101 and the Focal Epilepsy Landscape TranscriptJul 12, 2021
- Q1 2021 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2021$17.93 (-1.27%)Earnings
- Full Year 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2021$17.92 (-4.07%)Earnings
- Q3 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020$11.85 (+5.52%)Earnings
- Q2 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020$11.3 (-1.22%)Earnings
- Xenon Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 01, 2020
- Q1 2020 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 21, 2020$13.87 (-2.94%)Earnings
- Q4 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 09, 2020$12.12 (-14.53%)Earnings
- Xenon Pharmaceuticals Inc. - Special Call TranscriptDec 02, 2019
- Q3 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019$9.15 (+1.44%)Earnings
- Q2 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019$9.18 (+2.80%)Earnings
- Q1 2019 Xenon Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2019$9.5 (-2.46%)Earnings
- Full Year 2018 Xenon Pharmaceuticals Inc Earnings Call TranscriptMar 06, 2019$8.78 (+1.27%)Earnings
Xenon Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 07, 2022 / 06:10PM GMT
Release Date Price:
$36.02
(-5.19%)
Operator
Ladies and gentlemen, the program is about to begin. (Operator Instructions) At this time, it is my pleasure to turn the program over to your host, Jason Gerberry.
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
Good day, everybody. Thanks so much for joining us at the BofA Biotech conference that's being conducted virtually. My name is Jason Gerberry. I'm one of the biotech analysts, and I'm pleased to be introducing Xenon Pharmaceuticals and CEO, Ian Mortimer; and CFO, Sherry Aulin. So thanks so much to both of you for first all for joining us at the event.
Ian C. Mortimer
Xenon Pharmaceuticals Inc. - President, CEO & Director
Thanks, Jason.
Questions & Answers
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
So obviously, the first place that most of these conversations for you, I imagine, start is with your lead drug 1101, your potassium channel opener for focal-onset epilepsy
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)